Medicenna TherapeuticsCorp - Delisted Stock
Medicenna TherapeuticsCorp is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Medicenna TherapeuticsCorp was actively traded.
Valuation
Fiscal Year End 25th of June 2024
Medicenna TherapeuticsCorp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Medicenna TherapeuticsCorp market risk premium is the additional return an investor will receive from holding Medicenna TherapeuticsCorp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Medicenna TherapeuticsCorp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Medicenna TherapeuticsCorp's alpha and beta are two of the key measurements used to evaluate Medicenna TherapeuticsCorp's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.63 | |||
| Semi Deviation | 6.14 | |||
| Standard Deviation | 8.97 | |||
| Variance | 80.41 |
View Medicenna TherapeuticsCorp Related Equities
| Risk & Return | Correlation |
Medicenna TherapeuticsCorp Corporate Management
Elected by the shareholders, the Medicenna TherapeuticsCorp's board of directors comprises two types of representatives: Medicenna TherapeuticsCorp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicenna. The board's role is to monitor Medicenna TherapeuticsCorp's management team and ensure that shareholders' interests are well served. Medicenna TherapeuticsCorp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicenna TherapeuticsCorp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fahar Merchant | Chairman, Founder | Profile | |
| MBBS MD | Acting Devel | Profile | |
| MESc BSc | Chief Founder | Profile | |
| Samuel MD | Scientific Advisor | Profile |
Still Interested in Medicenna TherapeuticsCorp?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Medicenna Stock
If you are still planning to invest in Medicenna TherapeuticsCorp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medicenna TherapeuticsCorp's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |